Long-term health-related quality of life after primary treatment for localized prostate cancer: Results from the CaPSURE registry

European Urology

Volumn 68, Issue 4, 2015, Pages 600-608

  Punnen, Sanoj ^a   Cowan, Janet E ^b   Chan, June M ^b   Carroll, Peter R ^b   Cooperberg, Matthew R ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HRQOL; Prostate cancer; Treatment

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; DISEASE SURVEILLANCE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MICTURITION; NERVE SPARING RADICAL PROSTATECTOMY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; SEXUAL FUNCTION; WATCHFUL WAITING; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; PSYCHOLOGY; QUESTIONNAIRE; REGISTER; RISK FACTOR; STATISTICAL MODEL; SURVIVOR; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; REGISTRIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; WATCHFUL WAITING;

EID: 84941793369     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.08.074     Document Type: Article

References (16)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
2. M.G. Sanda, R.L. Dunn, J. Michalski, and et al. Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
3. G.J. Huang, N. Sadetsky, and D.F. Penson Health related quality of life for men treated for localized prostate cancer with long-term followup J Urol 183 2010 2206 2212
4. J.L. Gore, L. Kwan, S.P. Lee, R.E. Reiter, and M.S. Litwin Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer J Natl Cancer Inst 101 2009 888 892
5. Y. Pardo, F. Guedea, F. Aguiló, and et al. Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment J Clin Oncol 28 2010 4687 4696
6. M.J. Resnick, T. Koyama, K.-H. Fan, and et al. Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 2013 436 445
7. D.P. Lubeck, M.S. Litwin, J.M. Henning, and et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor Urology 48 1996 773 777
8. V. Ficarra, G. Novara, A. Galfano, and et al. Twelve-month self-reported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36) BJU Int 97 2006 274 278
9. M.S. Litwin, R.D. Hays, A. Fink, P.A. Ganz, B. Leake, and R.H. Brook The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure Med Care 36 1998 1002 1012
10. P.I. Karakiewicz, M.W. Kattan, S. Tanguay, and et al. Cross-cultural validation of the UCLA prostate cancer index Urology 61 2003 302 307
11. M.J. Barry Quality of life and prostate cancer treatment J Urol 162 1999 407
12. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
13. J.J. Chipman, M.G. Sanda, R.L. Dunn, and et al. Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice J Urol 191 2014 638 645
14. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis J Natl Cancer Inst 101 2009 878 887
15. V. Prabhu, G. Sivarajan, G.B. Taksler, J. Laze, and H. Lepor Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer Eur Urol 65 2014 52 57
16. J.T. Wei, R.L. Dunn, M.S. Litwin, H.M. Sandler, and M.G. Sanda Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905